G-Protein Coupled Receptors Market Growth Outlook: Why Analysts Expect Continued Expansion

G-Protein Coupled Receptors Market Report

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

G-Protein Coupled Receptors Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The g-protein coupled receptors market size has experienced strong growth in recent years. It is anticipated to increase from $3.4 billion in 2025 to $3.63 billion in 2026, at a compound annual growth rate (CAGR) of 6.8%. This historical growth can be attributed to the rise in neurotransmitter research, progress in receptor biology, the expansion of pharmaceutical R&D, developments in cell line creation, and innovations in assay technology.

The g-protein coupled receptors market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $4.77 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast period is attributable to the demand for precision drug targeting, AI-driven drug discovery initiatives, the growth of the biologics pipeline, advancements in receptor deorphanization research, and increased investment in translational research. Significant trends expected in the forecast period include the expanding use of GPCR targets in drug discovery, the broader application of high-throughput screening, a stronger focus on orphan receptor research, the evolution of cell-based assay technologies, and increased collaboration between academic institutions and pharmaceutical companies.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=64104111&type=smp&name=G-Protein%20Coupled%20Receptors%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

G-Protein Coupled Receptors Market Growth Factors: What’s Supporting Expansion?

The increasing incidence of cancer is anticipated to fuel the expansion of the G-protein-coupled receptors market going forward. Cancer is characterized by the uncontrolled proliferation of abnormal cells that can invade adjacent tissues and spread. These malignant cells may also disseminate throughout the body via the lymphatic and vascular systems. G-protein-coupled receptors are integral in regulating critical cancer processes, including proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the activation of invasion and metastasis. For instance, in January 2023, the American Cancer Society, a US-based professional organizations company, reported that 1,958,310 new cancer cases were diagnosed in the United States in 2023, an increase from the estimated 1.9 million new cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the G-protein coupled receptors market.

G-Protein Coupled Receptors Market Segment Analysis Spotlighting Growth Areas

The g-protein coupled receptors market covered in this report is segmented –

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands

2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays

3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:

1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines

2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays

3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors

4) By Ligands: Agonists, Antagonists, Inverse Agonists

G-Protein Coupled Receptors Market Trends Shaping Long-Term Demand

Leading firms within the G-protein coupled receptors sector are undertaking Initial Public Offerings (IPOs) with the aim of creating medications that target G protein-coupled receptors (GPCRs), seeking to speed up research and development, progress clinical trials, and introduce novel treatments for various ailments such as cancer, neurological disorders, and metabolic conditions. The capital acquired through these offerings is primarily designated to further the development of the companies’ primary product candidates, which address chronic metabolic and pulmonary diseases. More precisely, these funds are allocated to advance their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which is dedicated to therapies for diabetes and obesity. As an illustration, in February 2023, Structure Therapeutics Inc, a company based in the US, finalized its initial public offering (IPO), securing $161 million to further its work on G-protein coupled receptor (GPCR)-based therapeutics. The firm issued 10,740,000 American depositary shares (ADSs) at a price of $15.00 per ADS, a figure substantially higher than its initial forecasts. These shares commenced trading on the Nasdaq Global Market using the ticker symbol ‘GPCR’.

G-Protein Coupled Receptors Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the g-protein coupled receptors market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, Septerna

View The Full G-Protein Coupled Receptors Market Report:

https://thebusinessresearchcompany.com/report/G-protein-coupled-receptors-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

G-Protein Coupled Receptors Market Top Region By Revenue And Market Share

North America was the largest region in the G-protein coupled receptors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model